XM does not provide services to residents of the United States of America.

Qualcomm's interest in acquiring Intel has cooled, Bloomberg News reports



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>UPDATE 1-Qualcomm's interest in acquiring Intel has cooled, Bloomberg News reports</title></head><body>

Adds details, background throughout

Nov 25 (Reuters) -Qualcomm's QCOM.O interest in acquiring Intel INTC.O is said to have cooled due to complexities associated with the deal, Bloomberg News reported on Monday, citing people familiar with the matter.

The complexities associated with acquiring all of Intel has made a deal less attractive to Qualcomm, Bloomberg reported, saying that it is possible Qualcomm may look at pieces of Intel instead or rekindle its interest later.

The companies did not respond to a request for comment on the Bloomberg report outside regular business hours in the U.S.

Qualcomm had approached Intel to explore a potential acquisition in September, Reuters and others reported. A deal between the companies, which would be the sector's biggest, would face tough antitrust scrutiny globally as it would unite two major chip firms.

Reuters had also reported that Qualcomm explored the possibility of acquiring portions of Intel's design business, days before reports emerged on Qualcomm exploring a deal for all of Intel.

At that time, Intel said that Qualcomm had not approached it about a potential acquisition, while Qualcomm declined to comment.

Once the dominant force in chipmaking, Intel has in recent years ceded its manufacturing edge to rival TSMC 2330.TW and missed out on the generative artificial intelligence boom after missteps including passing on an investment in ChatGPT-owner OpenAI.

The company lost its spot in the Dow Jones Industrial Average after a 25-year run to Nvidia NVDA.O earlier this month. Intel shares are down over 50% this year.


Intel expects US to shave chip-making grant, sources say nL2N3MW0IO


Reporting by Gnaneshwar Rajan in Bengaluru; Editing by Varun H K

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.